PR Newswire·Oct 7, 2026, 7:03 AM ET

Emerging Biotechs Standardize on Veeva Basics to Accelerate Drug Development

More than 175 emerging biotechs are establishing a technology foundation using Veeva Basics pre-configured applications.
Biotechs are launching pre-validated applications within weeks to scale from startup to commercialization.
Veeva Basics provides unified, end-to-end applications for clinical, regulatory, quality, medical, & commercial operations.
Whitehawk Therapeutics replaced paper processes with Veeva Basics to improve regulatory & quality processes without an IT team.
Biotechs are shifting regulatory publishing strategies from outsourced to insourced using Veeva Submissions Publishing Basics.
Structure Therapeutics reported sharper quality control & faster regulatory timelines after insourcing submission publishing.
Veeva Basics applications are built on the Vault Platform to enable seamless infrastructure scaling.
The Veeva R&D & Quality Summit is scheduled for Oct. 20-21 in Boston exclusively for life sciences professionals.
Veeva Systems serves more than 1,500 customers ranging from large pharmaceutical companies to emerging biotechs.